THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ExodusPoint Capital Management, LP's Holding History (CIK: 0001736225)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 28,437 Value ($000) $0 Avg Close $9.31 Range $8.35 - $10.90
Q3 2024
Shares 38,018 Value ($000) $0 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 80,955 Value ($000) $1 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 80,755 Value ($000) $1 Avg Close $9.27 Range $8.21 - $11.71
Q3 2023
Shares 117,318 Value ($000) $1 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 103,681 Value ($000) $1 Avg Close $11.04 Range $9.98 - $12.03
Q1 2022
Shares 53,850 Value ($000) $515 Avg Close $9.80 Range $7.71 - $13.17
Q3 2021
Shares 14,791 Value ($000) $109 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 90,864 Value ($000) $1,319 Avg Close $18.78 Range $14.46 - $22.74
Q3 2020
Shares 18,472 Value ($000) $273 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 31,405 Value ($000) $659 Avg Close $25.69 Range $20.17 - $31.35